Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (TSE:BHC)
TSX:BHC
BHC Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$5.45 - C$15.43
Previous CloseN/A
Volume45.48K
Average Volume (3M)274.90K
Market Cap
$3.32B
Enterprise ValueC$33.37B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.09
Next Earnings
May 01, 2025EPS Estimate
1.22Last Dividend Ex-Date
Nov 10, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding367,803,400
10 Day Avg. Volume339,301
30 Day Avg. Volume274,900
Standard Deviation0.16
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.25
Price to Cash Flow (P/CF)1.40
P/FCF Ratio0.30
Enterprise Value/Market Cap10.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.38
Enterprise Value/Ebitda11.74
Forecast
1Y Price Target
C$12.30Price Target Upside20.81% Upside
Rating ConsensusHold
Number of Analyst Covering6
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBHC total revenue was significantly above estimates, showcasing strong performance.
Future GrowthGuidance for future revenue and adjusted EBITDA has been raised, suggesting confidence in continued growth.
Sales PerformanceBausch & Lomb sales exceeded projections, indicating robust demand in this segment.
Bears Say
Earnings PerformanceEarnings per share missed expectations, highlighting a potential area of concern.
Investor ConcernsThere is continued uncertainty regarding the future separation of B+L, contributing to investor fatigue over the situation.
Separation ProcessThe B+L separation process did not result in a transaction, which removes a major catalyst for Bausch Health Companies.
---
Options Prices
Currently, No data available
---
Ownership Overview
18.82% Insiders
4.04% Mutual Funds
42.73% Other Institutional Investors
29.92% Public Companies and Individual Investors
BHC FAQ
What was Bausch Health Companies’s price range in the past 12 months?
Bausch Health Companies lowest stock price was C$5.45 and its highest was C$15.43 in the past 12 months.
What is Bausch Health Companies’s market cap?
Bausch Health Companies’s market cap is $3.32B.
When is Bausch Health Companies’s upcoming earnings report date?
Bausch Health Companies’s upcoming earnings report date is May 01, 2025 which is in 68 days.
How were Bausch Health Companies’s earnings last quarter?
Bausch Health Companies released its earnings results on Feb 19, 2025. The company reported C$1.621 earnings per share for the quarter, missing the consensus estimate of C$1.622 by -C$0.001.
Is Bausch Health Companies overvalued?
According to Wall Street analysts Bausch Health Companies’s price is currently Undervalued.
Does Bausch Health Companies pay dividends?
Bausch Health Companies pays a Quarterly dividend of C$1.419 which represents an annual dividend yield of N/A. See more information on Bausch Health Companies dividends here
What is Bausch Health Companies’s EPS estimate?
Bausch Health Companies’s EPS estimate is 1.22.
How many shares outstanding does Bausch Health Companies have?
Bausch Health Companies has 367,803,400 shares outstanding.
What happened to Bausch Health Companies’s price movement after its last earnings report?
Bausch Health Companies reported an EPS of C$1.621 in its last earnings report, missing expectations of C$1.622. Following the earnings report the stock price went up 9.462%.
Which hedge fund is a major shareholder of Bausch Health Companies?
Currently, no hedge funds are holding shares in TSE:BHC
---
Bausch Health Companies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$12.30 (20.81% Upside)
C$12.30 (20.81% Upside)
Blogger Sentiment
Bullish
TSE:BHC Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 5.9%
Last 30 Days ▲ 5.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.50%
12-Months-Change
Fundamentals
Return on Equity
15.16%
Trailing 12-Months
Asset Growth
-1.94%
Trailing 12-Months
Company Description
Bausch Health Companies
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets.
---
BHC Company Deck
---
BHC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Bausch Health demonstrated strong operational and financial performance in 2024, with consecutive quarters of revenue and EBITDA growth, significant cash flow generation, and strategic advancements in key segments. However, challenges such as foreign exchange impacts, legal proceedings, and declines in certain segments present areas of concern.Read More>---
BHC Revenue Breakdown
47.34% Bausch + Lomb
25.69% Salix
12.23% International
10.77% Diversified Products
3.96% Solta Medical
---
BHC Stock 12 Month Forecast
Average Price Target
C$12.30
▲(20.81% Upside)
Technical Analysis
Best Analysts Covering BHC
1 Year
1 Year Success Rate
9/25 ratings generated profit
1 Year Average Return
-13.97%
reiterated a sell rating 4 months ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 36.00% of your transactions generating a profit, with an average return of -13.97% per trade.
---